Priavoid is a clinical stage drug development company based in Düsseldorf, Germany. Its therapeutic focus is on protein misfolding disorders in the area of neurodegeneration. Key component of Priavoid's technology is an anti-oligomeric or anti-prionic mode of action, that efficiently and effectively disassembles neurotoxic aggregates by using all-D-peptides.
View Top Employees from Priavoid GmbHWebsite | http://www.priavoid.com |
Revenue | $6 million |
Employees | 16 (7 on RocketReach) |
Founded | 2017 |
Address | Merowingerplatz 1a, Düsseldorf, North Rhine-Westphalia 40225, DE |
Phone | +49 178 6157925 |
Technologies |
JavaScript,
HTML,
PHP
+9 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Business Services General, Business Services |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 541714 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies |
Looking for a particular Priavoid GmbH employee's phone or email?
The Priavoid GmbH annual revenue was $6 million in 2024.
7 people are employed at Priavoid GmbH.
Priavoid GmbH is based in Düsseldorf, North Rhine-Westphalia.
The NAICS codes for Priavoid GmbH are [541714, 54171, 541, 5417, 54].
The SIC codes for Priavoid GmbH are [87, 873].